Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencingAmélie Bourhis, Arnaud Uguen|Pathology|2021Cited by 15